IDEXX Laboratories, Inc. (BMV:IDXX)

Market Cap	804.72B
Revenue (ttm)	80.36B
Net Income (ttm)	18.29B
Shares Out	n/a
EPS (ttm)	221.05
PE Ratio	43.99
Forward PE	40.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	184
Average Volume	22
Open	9,861.00
Previous Close	8,460.00
Day's Range	9,861.00 - 9,861.00
52-Week Range	7,650.00 - 9,980.00
Beta	n/a
RSI	84.89
Earnings Date	May 1, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: IDXX

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD